Experiments were carried out using 25 white laboratory rats. A model of dosed contusional trauma to the spinal cord at the TVIII level in rats was used to measure the areas of pathological cavities and the numbers of myelinated fibers in the outer zones of the white matter were counted after single rapid doses of human umbilical blood mononuclear cells transfected with a plasmid carrying the vegf and fgf2 genes into the injured area. Animals of the control group received the same cells in analogous conditions, but transfected with plasmid pEGFP-N2, carrying the gene for enhanced green fluorescent protein (egfp). By postadministration day 30, the total area of pathological cavities in the outer zones of the white matter on transverse sections of the spinal cord 3 mm from the trauma epicenter in the caudal direction was more than two times smaller in animals of the experimental group than in controls. The numbers of myelinated fibers in the same white matter zones at the same distance from the trauma epicenter in the caudal and rostral directions were an average of 20% greater than in controls, while at a distance of 5 mm in the rostral direction the number was 40–70% greater. Administration of the therapeutic genes vegf and fgf2 into the injured area decreased cavitation, restricted the processes of secondary degeneration and maintained the number of myelinated fibers in the damaged spinal cord.
Similar content being viewed by others
References
S. V. Lebedev, S. V. Timofeev, A. V. Zharkov, et al., “Loading tests and the BBB method for evaluation of impairments after contusional trauma to the spinal cord,” Byull. Eksperim. Biol., 145, No. 10, 471–476 (2008).
I. I. Salafutdinov, A. K. Shafigullina, M. E. Ralvach, et al., “The effects of the simultaneous expression of different isoforms of the vascular endothelial growth factor VEGF and basic fibroblast growth factor FGF2 on the proliferation of human umbilical vein endothelial cells HUVEC,” Klet. Transplant. Tkan. Inzhen., 5, No. 2, 62–67 (2010).
Yu. A. Chelyshev and I. V. Viktorov, “Cellular remyelinization techniques in spinal cord trauma,” Nevrol. Vestn. Bekhtereva, No. 1, 49–55 (2009).
Yu. A. Chelyshev and G. F. Shaimardanova, “Glial NG2 cells in neuroontogenesis and regeneration,” Nevrol. Vestn. Bekhtereva, 42, No. 4, 84–90 (2010).
R. L. Benton and S. R. Whittemore, “VEGF-165 therapy exacerbates secondary damage following spinal cord injury,” Neurochem. Res., 28, No. 11, 1693–1703 (2003).
R. P. Bunge, “The role of the Schwann cell in trophic support and regeneration,” J. Neurol., 242, 19–21 (1994).
C. T. Chen, N. H. Foo, W. S. Liu, and S. H. Chen, “Infusion of human umbilical cord blood cells ameliorates hind limb dysfunction in experimental spinal cord injury through anti-inflammatory, vasculogenic and neurotrophic mechanisms,” Pediatr. Neonatol., 49, No. 3, 77–83 (2008).
V. R. Dasari, K. K. Veeravalli, A. J. Tsung, et al., “Neuronal apoptosis is inhibited by cord blood stem cells after spinal cord injury,” J. Neurotrauma, 26, No. 11, 2057–2069 (2009).
F. Facchiano, E. Fernandez, S. Mancarella, et al., “Promotion of regeneration of corticospinal tract axons in rats with recombinant vascular endothelial growth factor alone and combined with adenovirus coding for this factor,” J. Neurosurg., 97, No. 1, 161–168 (2002).
D. H. Howang, B. G. Kim, E. J. Kim, et al., “Transplantation of human neural stem cells transduced with Olig 2 transcription factor improves locomotor recovery and enhances myelination in the white matter of rat spinal cord following contusive injury,” BMC Neurosci., 10, No. 1, 117–133 (2009).
R. R. Islamov, V. Chintalgattu, E. S. Pak, et al., “Induction of VEG and its Flt-1 receptor after sciatic nerve crush injury,” Neuroreport, 15, No. 13, 2117–2121 (2004).
M. C. Jimenez Hamann, C. H. Tator, and M. S. Shoichet, “Injectable intrathecal delivery system for localized administration of EGF and FGF-2 to the injured rat spinal cord,” Exp. Neurol., 194, No. 1, 106–119 (2005).
K. N. Kim, S. H. Oh, K. H. Lee, and D. H. Yoon, “Effect of human mesenchymal stem cell transplantation combined with growth factor infusion in the repair of injured spinal cord,” Acta Neurochir., 99, Supplement, 133–136 (2006).
Y. Nishio, M. Koda, T. Kamada, et al., “The use of hemopoietic stem cells derived from human umbilical cord blood to promote restoration of spinal cord tissue and recovery of hindlimb function in adult rats,” J. Neurosurg. Spine, 5, No. 5, 424–433 (2006).
C. Radtke,Y. Akiyama, J. Brokaw, et al., “Remyelination of the nonhuman primate spinal cord by transplantation of H-transferase transgenic adult pig olfactory ensheathing cells,” FASEB J., 18, No. 2, 335–337 (2004).
A. A. Rizvanov, A. P. Kiyasov, L. M. Gazizov, et al., “Human umbilical cord blood cells transfected with VEGF and L(1) CAM do not differentiate into neurons but transform into vascular endothelial cells and secrete neuron-trophic factors to support neuron-genesis – a novel approach in stem cell therapy,” Neurochem. Int., 53, No. 6–8, 389–394 (2008).
M. Sondell, G. Lundborg, and M. Kanje, “Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system,” J. Neurosci., 19, No. 14, 5731–5740 (1999).
M. Vendrame, J. Cassady, J. Newcomb, et al., “Infusion of human umbilical cord blood cells in a rat model of stroke dose-dependently rescues behavioral deficits and reduces infarct volume,” Stroke, 35, No. 10, 2390–2395 (2004).
Author information
Authors and Affiliations
Corresponding authors
Additional information
Translated from Morfologiya, Vol. 140, No. 6, pp. 36–42, November–December, 2011.
Rights and permissions
About this article
Cite this article
Shaimardanova, G.F., Mukhamedshina, Y.O., Arkhipova, S.S. et al. Post-Traumatic Changes in the Spinal Cord in Rats after Transplantation of Mononuclear Cells from Human Umbilical Blood Modified with the vegf and fgf2 Genes. Neurosci Behav Physi 42, 1012–1018 (2012). https://doi.org/10.1007/s11055-012-9671-2
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11055-012-9671-2